Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 574,231 | 671,028 | 670,301 | 634,441 | 912,973 |
| Marketable Securities | 238,884 | 239,174 | 215,947 | 163,528 | 118,636 |
| Receivables | 398,674 | 375,031 | 394,913 | 388,554 | 387,996 |
| Inventories | 433,510 | 445,581 | 449,337 | 429,975 | 398,100 |
| Income taxes - deferred | 53,777 | N/A | N/A | N/A | 48,021 |
| TOTAL | $1,798,155 | $1,877,703 | $1,889,656 | $1,797,310 | $1,975,346 |
| Non-Current Assets | |||||
| PPE Net | 349,501 | 338,942 | 348,439 | 337,625 | 333,617 |
| Intangibles | 728,430 | 551,455 | 594,550 | 567,765 | 567,862 |
| Other Non-Current Assets | 220,717 | 201,695 | 211,600 | 206,073 | 185,939 |
| TOTAL | $1,298,648 | $1,092,092 | $1,154,589 | $1,111,463 | $1,087,418 |
| Total Assets | $3,096,803 | $2,969,795 | $3,044,245 | $2,908,773 | $3,062,764 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 129,124 | 113,476 | 120,514 | 111,373 | 113,440 |
| Accrued Expenses | 112,564 | 120,167 | 122,254 | 116,733 | 131,381 |
| Other current liabilities | 114,787 | 112,900 | 122,953 | 110,520 | 93,104 |
| TOTAL | $459,115 | $415,326 | $442,844 | $427,591 | $666,627 |
| Non-Current Liabilities | |||||
| Long Term Debt | 731,698 | 731,597 | 731,331 | 731,214 | 731,100 |
| Deferred Revenues | 24,322 | N/A | N/A | N/A | 20,642 |
| Other Non-Current Liabilities | 76,124 | 129,261 | 144,181 | 136,581 | 64,751 |
| TOTAL | $893,306 | $860,823 | $875,486 | $867,694 | $855,618 |
| Total Liabilities | $1,352,421 | $1,276,149 | $1,318,330 | $1,295,285 | $1,522,245 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,200 | 28,121 | 28,063 | 28,002 | 27,880 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,359,910 | 1,300,671 | 1,254,774 | 1,214,726 | 1,181,687 |
| Other shareholders' equity | 199,135 | 213,132 | 296,646 | 230,856 | 201,843 |
| TOTAL | $1,744,382 | $1,693,646 | $1,725,915 | $1,613,488 | $1,540,519 |
| Total Liabilities And Equity | $3,096,803 | $2,969,795 | $3,044,245 | $2,908,773 | $3,062,764 |